The studies provided do not contain research on Lactobacillus salivarius or its use in relation to H. pylori support. The two available studies address unrelated topics: one examines cross-reactive antibodies between gut bacteria and SARS-CoV-2, and the other introduces a computational tool for analyzing microbial communities. Research suggests that while the broader relationship between gut microbiota and immune function is an active area of investigation, no conclusions about Lactobacillus salivarius and H. pylori can be drawn from this particular set of studies. Anyone seeking evidence on this specific topic should consult sources that directly investigate Lactobacillus salivarius in the context of H. pylori colonization or treatment outcomes.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Pre-existing antibodies targeting a linear epitope on SARS-CoV-2 S2 cross-rea... | Other | 2021 | Neutral | 90 |
| Extending and improving metagenomic taxonomic profiling with uncharacterized ... | Other | 2022 | Neutral | 85 |